Newsfeeds - Spark Newswire

1 minute read

Acasti Pharma Q3 EPS $(0.09) Beats $(0.11) Estimate, Cash Balance Of $31.3M With Cash Runway Into Q2 Of 2024

Today, 1:53 PM

Acasti Pharma (NASDAQ:ACST) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. This is unchanged from the same period last year.

ACST

8 minute read

Earnings

Earnings Scheduled For February 14, 2023

By Benzinga Insights

Today, 1:53 PM

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

ABNB

3 minute read

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

Today, 1:53 PM

Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets.

ABVC

3 minute read

Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket

By Lisa Levin

Today, 1:53 PM

Gainers Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer available through SUV dealerships nationwide.

$APE

1 minute read

EF Hutton Initiates Coverage On Acasti Pharma with Buy Rating, Announces Price Target of $2.5

By Benzinga Newsdesk

Today, 1:53 PM

EF Hutton analyst Constantine Davides initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Buy rating and announces Price Target of $2.5.

ACST

1 minute read

HC Wainwright & Co. Initiates Coverage On Acasti Pharma with Buy Rating, Announces Price Target of $2.4

By Benzinga Newsdesk

Today, 1:53 PM

HC Wainwright & Co. analyst Oren Livnat initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Buy rating and announces Price Target of $2.4.

ACST

9 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 1:53 PM

On Friday, 127 companies set new 52-week lows.

$APE

13 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 1:53 PM

Wednesday saw 219 companies set new 52-week lows.

$APE

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

Today, 1:53 PM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

5 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 1:53 PM

On Friday, 63 stocks hit new 52-week lows.

ACEV